Trial NCT02292225

View at ClinicalTrials.gov 
Org. Study IDs: IPI-145-18

Last trial update was posted on 2023-02-27

MeSH Interventions

Obinutuzumab

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Other Conditions

Lymphocytic Leukemia, Chronic Lymphoma, Small Lymphocytic

Stopping Reasons

The scope of the program has been reduced to focus resources on studies which can potentially enable the registration of duvelisib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID